We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
-2.36%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$58.2B
AUM Growth
-$3.82B
(-6.2%)
Cap. Flow
-$2.56B
Cap. Flow
% of AUM
-4.4%
Top 10 Holdings %
Top 10 Hldgs %
42.63%
Holding
1,057
New
84
Increased
369
Reduced
421
Closed
149
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$516M |
| 2 |
Walt Disney
DIS
|
+$214M |
| 3 |
O'Reilly Automotive
ORLY
|
+$143M |
| 4 |
Nike
NKE
|
+$66.8M |
| 5 |
Arm
ARM
|
+$58.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$724M |
| 2 |
NVIDIA
NVDA
|
+$604M |
| 3 |
Meta Platforms (Facebook)
META
|
+$458M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$118M |
| 5 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.13% |
| 2 | Communication Services | 16.86% |
| 3 | Consumer Discretionary | 16.15% |
| 4 | Healthcare | 13.57% |
| 5 | Financials | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALE
326
DELISTED
Allete
ALE
| $9.61M | 0.02% |
181,906
-3,716
| -2% | -$209K |
|
327
ANI Pharmaceuticals
ANIP
$1.72B
| $9.59M | 0.02% |
165,229
-3,426
| -2% | -$198K |
|
328
Kemper
KMPR
$1.55B
| $9.52M | 0.02% |
226,390
-4,796
| -2% | -$228K |
|
|
GTLS
329
DELISTED
Chart Industries
GTLS
| $9.48M | 0.02% |
56,069
-3,995
| -7% | -$672K |
|
330
Nexstar Media Group
NXST
$5.91B
| $9.46M | 0.02% |
65,994
-4,844
| -7% | -$786K |
|
331
Columbus McKinnon
CMCO
$557M
| $9.27M | 0.02% |
265,585
+3,591
| +1% | +$137K |
|
332
XP
XP
$8.37B
| $9.19M | 0.02% |
+398,735
| New | +$10M |
|
333
International Money Express
IMXI
$356M
| $9.03M | 0.02% |
533,323
-10,921
| -2% | -$220K |
|
334
State Street Blackstone Senior Loan ETF
SRLN
$5.35B
| $8.99M | 0.02% |
214,506
+17,366
| +9% | +$726K |
|
335
Viavi Solutions
VIAV
$9.18B
| $8.92M | 0.02% |
976,348
-19,677
| -2% | -$205K |
|
336
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| $8.88M | 0.02% |
120,419
+47,249
| +65% | +$3.53M |
|
337
TransUnion
TRU
$15.2B
| $8.69M | 0.01% |
121,093
+2,664
| +2% | +$209K |
|
338
John Wiley & Sons Class A
WLY
$2.62B
| $8.67M | 0.01% |
233,300
-4,707
| -2% | -$167K |
|
339
AMN Healthcare
AMN
$1.42B
| $8.61M | 0.01% |
101,059
-114,242
| -53% | -$10.8M |
|
340
Antero Resources
AR
$11.4B
| $8.48M | 0.01% |
334,329
+36,932
| +12% | +$953K |
|
|
BELFB
341
Bel Fuse Inc Class B
BELFB
$4.1B
| $8.38M | 0.01% |
+175,543
| New | +$9.05M |
|
|
MDRX
342
DELISTED
Veradigm Inc. Common Stock
MDRX
| $8.15M | 0.01% |
620,019
-12,561
| -2% | -$165K |
|
343
VSE Corp
VSEC
$6.21B
| $7.95M | 0.01% |
157,610
+21,730
| +16% | +$1.18M |
|
344
Scholastic
SCHL
$807M
| $7.8M | 0.01% |
204,650
-8,574
| -4% | -$356K |
|
345
Planet Fitness
PLNT
$3.7B
| $7.75M | 0.01% |
157,550
-139,880
| -47% | -$8.46M |
|
346
Leidos
LDOS
$17.5B
| $7.55M | 0.01% |
81,925
+22,478
| +38% | +$2.12M |
|
347
Rexford Industrial Realty
REXR
$8.13B
| $7.49M | 0.01% |
151,709
-11,920
| -7% | -$630K |
|
348
Rogers Corp
ROG
$2.29B
| $7.41M | 0.01% |
56,370
-67,096
| -54% | -$10M |
|
349
Academy Sports + Outdoors
ASO
$3.09B
| $7.38M | 0.01% |
+156,117
| New | +$8.36M |
|
350
Vanguard Morningstar Growth ETF
VUG
$230B
| $7.21M | 0.01% |
158,766
+130,614
| +464% | +$6.17M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q3 2023 Portfolio in Review
As of Q3 2023, Loomis, Sayles & Company held 1,057 positions worth $58.2B, down 6.2% from $62B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Loomis, Sayles & Company withdrew a net $2.56B in Q3 2023, closing 149 positions and reducing 421 holdings. Its most notable exit was Callaway Golf Company, an estimated $62.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Loomis, Sayles & Company opened a new position in Arm worth $57M.
- Loomis, Sayles & Company's largest Q3 2023 buy was Arm: 1,065,084 shares worth $57M.
- Loomis, Sayles & Company added most to Thermo Fisher Scientific in Q3 2023, an estimated $516M increase.
- Loomis, Sayles & Company's biggest Q3 2023 reduction was Bank of America Series L, cutting an estimated $724M.
- Loomis, Sayles & Company fully exited Callaway Golf Company in Q3 2023, selling an estimated $62.5M.
- Loomis, Sayles & Company's ten largest holdings make up 43% of its $58.2B portfolio in Q3 2023.
- Loomis, Sayles & Company opened 84 new positions and closed 149 in Q3 2023.
- Loomis, Sayles & Company's portfolio value fell 6.2% quarter-over-quarter to $58.2B.
Based on Loomis, Sayles & Company's 13F filing for Q3 2023, filed 9 Nov 2023.